Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021773

Expand all

BYETTA (EXENATIDE SYNTHETIC)
300MCG/1.2ML (250MCG/ML) Marketing Status: Prescription

Active Ingredient: EXENATIDE SYNTHETIC
Proprietary Name: BYETTA
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: 300MCG/1.2ML (250MCG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021773
Product Number: 001
Approval Date: Apr 28, 2005
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:  Prescription
Patent and Exclusivity Information

BYETTA (EXENATIDE SYNTHETIC)
600MCG/2.4ML (250MCG/ML) Marketing Status: Prescription

Active Ingredient: EXENATIDE SYNTHETIC
Proprietary Name: BYETTA
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: 600MCG/2.4ML (250MCG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021773
Product Number: 002
Approval Date: Apr 28, 2005
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English